Activin-A impairs CD8 T cell-mediated immunity and immune checkpoint therapy response in melanoma.

J Immunother Cancer · 2022 · PMC9125758 · PMID 35580932

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

We observed a clear trend of Activin-A to diminish immune infiltrates that was associated with a significant reduction of CTL and NK cell proportions ( figure 1A–C ).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.